- Home
- BPTH vs ATCH Comparison
BPTH vs ATCH Comparison
Compare BPTH & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPTH
- ATCH
- Stock Information
- Founded
- BPTH 2007
- ATCH 2022
- Country
- BPTH United States
- ATCH United States
- Employees
- BPTH N/A
- ATCH N/A
- Industry
- BPTH Biotechnology: Pharmaceutical Preparations
- ATCH
- Sector
- BPTH Health Care
- ATCH
- Exchange
- BPTH Nasdaq
- ATCH Nasdaq
- Market Cap
- BPTH 2.2M
- ATCH 2.5M
- IPO Year
- BPTH N/A
- ATCH N/A
- Fundamental
- Price
- BPTH $0.87
- ATCH $0.22
- Analyst Decision
- BPTH Strong Buy
- ATCH
- Analyst Count
- BPTH 2
- ATCH 0
- Target Price
- BPTH $30.00
- ATCH N/A
- AVG Volume (30 Days)
- BPTH 81.3K
- ATCH 8.8M
- Earning Date
- BPTH 11-13-2024
- ATCH 11-20-2024
- Dividend Yield
- BPTH N/A
- ATCH N/A
- EPS Growth
- BPTH N/A
- ATCH N/A
- EPS
- BPTH N/A
- ATCH 0.04
- Revenue
- BPTH N/A
- ATCH N/A
- Revenue This Year
- BPTH N/A
- ATCH N/A
- Revenue Next Year
- BPTH N/A
- ATCH N/A
- P/E Ratio
- BPTH N/A
- ATCH $4.97
- Revenue Growth
- BPTH N/A
- ATCH N/A
- 52 Week Low
- BPTH $0.86
- ATCH $0.14
- 52 Week High
- BPTH $21.60
- ATCH $10.26
- Technical
- Relative Strength Index (RSI)
- BPTH 34.38
- ATCH 48.37
- Support Level
- BPTH $0.86
- ATCH $0.18
- Resistance Level
- BPTH $0.92
- ATCH $0.24
- Average True Range (ATR)
- BPTH 0.06
- ATCH 0.04
- MACD
- BPTH 0.01
- ATCH 0.01
- Stochastic Oscillator
- BPTH 5.79
- ATCH 27.97
About BPTH Bio-Path Holdings Inc.
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.